18 June 2021 : Clinical Research
Relationship of Bone Status with Serum Uric Acid and Bilirubin in Men with Type 2 Diabetes: A Cross-Sectional Study
Yang Wu1ABCDEF, Shoukui Xiang1BCDE, Xiaohong Jiang1B, Long Wang1BF, Kun Wang2AG, Fei Hua1AG*DOI: 10.12659/MSM.930410
Med Sci Monit 2021; 27:e930410
Table 4 The influence of the change in serum UA and TBIL on the prevalence of osteoporosis and osteopenia in male patients with T2DM.
| UA | TBIL | |||
|---|---|---|---|---|
| OR (95% CI) | p | OR (95% CI) | p | |
| Unadjusted | 0.996 (0.994, 0.998) | 0.000 | 0.965 (0.926, 1.004) | 0.080 |
| MV adjusted | 0.996 (0.994, 0.998) | 0.001 | 0.944 (0.899, 0.992) | 0.023 |
| MV included: age, BMI, duration of T2DM, smoking habit, alcohol intake, history of hypertension, use of insulin or analogs, HbA1c, FBG, albumin, creatinine, total cholesterol, triglyceride, HDL, LDL, 25(OH)D3. UA – uric acid; TBIL – total bilirubin; MV – multiple variables; BMI – body index; T2DM – type 2 diabetes mellitus; HbA1c – glycosylated hemoglobin; FBG – fasting blood glucose; HDL – high-density lipoprotein; LDL – low-density lipoprotein. | ||||